baber/WOPTO huggingface dataset:
Patent CA-2555888-A1 (CA)
Title: Reversible lined drapery
Inventor: MACHA MONICA
IPC: A47H23/00
Filed: 2005-02-10
Abstract: A reversible drape includes lining with an opening through which the drapery can be inverted so that a first decorative fabric is displayed on one side of the drapery, the lining is displayed on the other side, and the heading of the first decorative fabric is at the top of the drape, while a second decorative fabric preferably is disposed entirely within the drapery body along with the heading of the second decorative fabric. The drapery may be inverted again through the opening in the lining, so that the second decorative fabric is displayed on one side of the drapery, the lining is displayed on the other side, and the heading of the second decorative fabric is at the top of the drape, while the first decorative fabric preferably is disposed entirely within the drapery body along with the heading of the first decorative fabric now at the bottom of the drapery body. This reversibility allows one fabric to be selectively displayed with a second fabric hidden inside the drape and a third fabric preferably always visible on back of the drape regardless of whether the first fabric or the second fabric is showing on the front of the drape. The construction of the drapery allows the raw edges to be hidden regardless of which decorative fabric is shown.
Patent CA-2557324-A1 (CA)
Title: Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
Inventor: CHRISTGAU STEPHAN
IPC: A61K33/24
Filed: 2005-02-28
Abstract: A method for the treatment and/or prophylaxis of an ostenonecrotic bone disease in a mammal in need thereof, such as, e.g., idiopathic or secondary osteonecrosis, avascular bone necrosis, glucocorticoid induced bone ischemia/osteonecrosis, Legg-Calve-Perthes disease and femoral head necrosis, the method comprising administering an effective dose of a strontium-containing compound (a) to the mammal. A method for the treatment and/or prophylaxis of an osteonecrotic bone disease, such as, e.g., idiopathic or secondary osteonecrosis, avascular bone necrosis, glucocorticoid induced bone ischemia/osteonecrosis and femoral head necrosis, in a mammal who is to be or is treated with a therapeutic agent (b) known to or suspected of inducing apoptosis and/or necrosis of bone cells, the method comprising administering a strontium-containing compound (a) in combination with (b).
Patent CA-2558557-A1 (CA)
Title: Pilot transmission and channel estimation for miso and mimo systems
Inventor: KADOUS TAMER
IPC: H04B7/06
Filed: 2005-03-02
Abstract: A transmitter generates multiple composite pilots with a training matrix and a gain matrix. Each composite pilot includes multiple training pilots generated with multiple columns of the training matrix and scaled with multiple gain elements in a column of the gain matrix. The transmitter transmits each composite pilot via multiple transmit antennas. A MISO receiver obtains received symbols for the multiple composite pilots and derives an estimate of a composite MISO channel. For OFDM, the MISO receiver derives an initial impulse response estimate for each composite pilot, filters the initial impulse response estimates for all composite pilots, and derives a frequency response estimate for the composite MISO channel. A MIMO receiver obtains and processes received symbols for the multiple composite pilots based on the training and gain matrices and derives channel estimates for individual SISO  channels between the multiple transmit antennas and multiple receive antennas.
Patent CA-2559791-A1 (CA)
Title: Secreted proteins as markers for cell differentiation
Inventor: EHLICH ANDREAS
IPC: C12Q1/68
Filed: 2004-07-08
Abstract: Provided are means and methods for in vitro and in vivo detection of chemically induced effects on embryonic development and differentiation for the purpose of embryotoxicity/teratogenicity screening as well as for the identification of pharmaceuticals such as growth and tissue promoting factors based on differentiating pluripotent embryonic stem (ES) cells. The assays are based on the use of transgenic ES cells and non-human animals comprising such ES cells or derivatives thereof, wherein said ES cells are characterized by the differentiation-dependent expression of a secreted reporter protein; in particular secreted embryonic alkaline phosphatase (SEAP).
Patent CA-2560649-A1 (CA)
Inventor: HADDAD EL-BDAOUI
IPC: A61K31/4535
Filed: 2005-03-24
Abstract: The present invention extends to the compound of formula I, or a prodrug, pharmaceutically acceptable salt, or solvate of said compound. Furthermore, the present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier. Furthermore, the present invention is directed to the use of a compound of formula I as an inhibitor of tryptase, comprising introducing the compound into a composition comprising tryptase. In addition, the present invention is directed to the use of a compound of formula I for treating a patient suffering from, or subject to, a physiological condition in need of amelioration of an inhibitor of tryptase comprising administering to the patient a therapeutically effective amount of the compound of Claim 1. The present invention is directed also to the preparation of a compound of formula I.
Patent CA-2564837-A1 (CA)
Title: Internal control in situ hybridization
Inventor: JI JAY
IPC: C12Q1/70
Filed: 2005-05-04
Abstract: The invention provides a method for monitoring the quality ofin situ hybridization analysis of a nuclear DNA target in a tissue or cell sample using a mitochondrial DNA probe as an internal control. The invention also provides a reagent for in situ hybridization detection of a nuclear DNA target and a mitochondrial DNA target in a tissue or cell sample.
Patent CA-2565220-A1 (CA)
Inventor: ANGMAN PER G
IPC: E21B23/00
Filed: 2006-10-23
Abstract: A method for securing a wellbore string device to a wellbore liner tubular employs a swelling elastomer to frictionally grip a gap between the wellbore string device and the liner tubular. The swelling elastomer is positioned between the wellbore string device and the wellbore liner tubular, then activated to cause it to swell to engage the wellbore string device with the wellbore liner tubular. The wellbore string device may be a centralizer, a wear band or a torque ring.
Patent CA-2566700-A1 (CA)
Title: Space-time block coding in orthogonal frequency division communication systems
Inventor: NAGUIB AYMAN FAWZY
IPC: H04L1/06
Filed: 2005-04-29
Abstract: Transmitters, receivers, and methods for providing improved transmit diversity orthogonal frequency division multiplexed communication systems is provided.
Patent CA-2568298-A1 (CA)
Inventor: TRUMMER STEFAN
IPC: C09D5/08
Filed: 2005-06-01
Abstract: The invention relates to an aqueous coating composition, comprising at least one water-compatible film-forming agent and at least one aluminium pigment with an inorganic corrosion resistant layer, the thickness of the aluminium pigment, with at least one inorganic corrosion resistant layer, in the agent, being less than 160 nm. The invention further relates to a method for production of such a coating composition, the use of such a coating composition and objects coated with the coating composition.
Patent CA-2571125-A1 (CA)
Inventor: GOTO YOSHIHIRO
IPC: B65D71/08
Filed: 2005-07-04
Abstract: An overwrap package, a perforation forming method, and a perforation forming device. The overwrap package is formed by heat-shrinking a wrapper in the state of collectively packaging five beverage commodities by the wrapper.  Three perforations passing the clearance portions of the adjacent beverage commodities are formed in the wrapper parallel with each other at intervals of 2 mm. When the three perforated portions of the overwrap package at the clearance portions of the beverage commodities are pressed by a finger, the wrapper is broken in the vertical direction, and the packaged beverage commodities can be easily taken out one by one.
Patent CA-2572208-A1 (CA)
Title: 3-carbamoyl-2-pyridone derivative
Inventor: ODAN MASAHIDE
IPC: A61K31/4439
Filed: 2005-10-28
Abstract: A compound represented by the general formula (I): (wherein R1 is optionally substituted C1-8 alkyl, etc.; R2 is C1-6 alkyl and R3 is C1-6 alkyl, etc., provided that R2 and R3 may be bonded to each other to form an optionally substituted 5- to 10-membered nonaromatic carbocycle; R4 is hydrogen, etc.;  and G is a group selected among, e.g., groups represented by the formula (X) (wherein R5 is hydrogen, etc.; X1 is a single bond, etc.; X2 is, e.g., optionally substituted C1-8 alkylene optionally having one or two atoms or groups selected between -O- and -N(R6)- (R6 is hydrogen, etc.); X3 is a single bond, etc.; Y is -O-, etc.; and Z is hydrogen, etc.)), a pharmaceutically acceptable salt of the compound, or a solvate of either. These compounds have cannabinoid receptor agonistic activity. Also provided are a medicinal composition, an atopic dermatitis remedy, and an anti-itching agent, especially an anti-itching agent for oral administration or for external use, which each contains any of those compounds as an active ingredient.
Patent CA-2572324-A1 (CA)
Title: Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
Inventor: ROARK WILLIAM HOWARD
IPC: A61K31/41
Filed: 2004-06-21
Abstract: This invention relates to a combination of an allosteric inhibitor of matrix metalloproteinase-13, or a pharmaceutically acceptable salt thereof, and a ligand to an alpha-2-delta receptor, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the combination, and a method of using the combination to treat a disease or disorder in a mammal suffering therefrom, wherein the disease or disorder is responsive to treatment in one aspect by an allosteric inhibitor of MMP-13 and in the same or a different aspect by a ligand to an alpha-2-delta receptor.
Patent CA-2573077-A1 (CA)
Title: Flatness monitor
Inventor: CHUPIL VICTOR
IPC: G01B11/30
Filed: 2005-07-18
Abstract: A system method of monitoring flatness of a material. A beam of coherent light is projected on to a surface of the material to provide a line on the surface.  An image of the line on the surface is obtained, and the image is used to determine a deviation of the line from a predetermined configuration. The deviation corresponds to an irregular pattern or unevenness of the material.
Patent CA-2577947-A1 (CA)
Inventor: SATO YOSHIYUKI
IPC: C07D471/04
Filed: 2005-08-30
Abstract: Compounds represented by the general formula [I] or pharmaceutically acceptable salts or esters thereof; and PLK1 inhibitors and anticancer drugs, containing the same: [I] wherein X1, X2, X3 and X4 are each independently C or N (with the proviso that zero to two of X1, X2, X3 and X4 are N); Y is CH or N; R1, R1 ', R2, R2 ', R3, R3 ', R4and R4 ' are each independently hydrogen, lower alkyl, or the like; R5 is hydrogen or methyl; R6 and R7 are each independently hydrogen, lower alkyl, or the like; R8 and R8 ' are each independently hydrogen, lower alkyl, or the like; R9 is optionally substituted aryl or heteroaryl; and n is an integer of 1 to 3.
Patent CA-2578235-A1 (CA)
Title: Controlled cycle-life jaw assembly
Inventor: BOWLES RICHARD R
IPC: B25B27/14
Filed: 2005-09-09
Abstract: A jaw assembly for use with a crimping tool is described, wherein the assembly includes a jaw arm and a side plate where the side plate is configured to fail in a manner noticeable to a user of the jaw assembly prior to the anticipated failure of the jaw arm. The side plate includes a stress riser, such as a milled slot formed in one face of the sideplate, to ensure such failure.
Patent CA-2579576-A1 (CA)
Title: Improved ghb compositions
Inventor: MAMELAK MORTIMER
IPC: A61K31/70
Filed: 2005-09-07
Abstract: The invention provides a combination of sodium gamma-hydroxybutyrate (GHB) or a prodrug or an analog thereof, with a compound that inhibits the metabolism of the GHB or GHB analog in vivo, thus prolonging or enhancing the bioactivity thereof.
Patent CA-2580206-A1 (CA)
Inventor: KELLER ARNOLD
IPC: A61F2/44
Filed: 2005-06-13
Abstract: The invention relates to a prosthesis for the partial replacement of a vertebral body, comprising an upper connection plate (5) for connecting to an upper vertebral body (1), a lower connection plate (6) for connecting to a lower vertebral body (2) and a bridging part (7), which interconnects the upper and lower connection plates (5, 6) with the inclusion of at least one articulation for bridging at least one vertebral body (3) that lies between the upper and lower vertebral bodies (1, 2) and is to be partially replaced.  The bridging part (7) is accommodated in a cavity of the vertebral body (3).  The bridging part comprises lateral anchor projections (9) to secure it in the cavity, said projections penetrating the osseous material that lies on both sides of the bridging part (7). The cross-section of said part narrows towards the rear, preferably having a trapezoidal shape.
Patent CA-2580795-A1 (CA)
Title: Methods and compositions for evaluating breast cancer prognosis
Inventor: MALINOWSKI DOUGLAS P
IPC: G16B20/00
Filed: 2005-09-22
Abstract: Methods and computer program products for evaluating and optimizing one or more markers for use in establishing a prognosis for a patient suffering from a disease are provided. More particularly, the methods include steps for systematically evaluating a number of features that may be extracted from an image of a body sample, such as a histological slide, that has been exposed to one or more biomarkers so as to establish a prognostic decision rule based on one or more of the extracted features such that the decision rule yields a prognosis that is optimally predictive of actual patient outcome. Thus, the methods and computer program products provided yield optimally predictive prognoses to assist clinicians in developing strategies for effective patient care management.
Patent CA-2583271-A1 (CA)
Inventor: BUSCH BRETT B
IPC: C07D277/54
Filed: 2005-10-21
Abstract: Compounds for use in compositions and methods for modulating the activity of nuclear receptors are provided. In particular, compounds for use in compositions and methods for modulating the estrogen related receptors are provided. In one embodiment, the compounds provided herein are ERR modulators.  In another embodiment, the compounds provided herein are agonists, partial agonists, antagonists. or inverse agonists of ERR or ERR. In certain embodiments, the compounds of the invention, as described above in the Summary of the Invention, are compounds of formula (I).
Patent CA-2583460-A1 (CA)
Title: Homologous amds genes as selectable marker
Inventor: WINDE DE JOHANNES HENDRIK
IPC: C12N9/80
Filed: 2005-10-17
Abstract: The present invention relates to novel functional amdS genes from A.niger that can be used as dominant and bi-directional selection marker gene in the transformation of organisms. The present invention further relates to the production of a compound of interest in a fungal host cell transformed with the amdS genes of the invention. Preferred fungal host cells are filamentous fungal cells. The amdS genes of the invention provide means for identification of functional homologues in other Aspergillus species.
Patent CA-2583619-A1 (CA)
Inventor: STEFANISON IAN
IPC: G06F9/44
Filed: 2007-04-02
Abstract: The invention provides a method of data interaction on forms in a web-based database application environment comprising the steps of: invoking a software routine operable to:  invoke Flash objects; receive form data from the web-based database application and transfer that form data to Flash objects; and receive Flash object data and transfer that data back to the web client for placement into the form. The invention also provides a system comprising: a personal computer operable to execute: a web client module; a Flash Object module; and a web client/Flash interface module; the web client module being operable to execute web pages and forms; and the web client/Flash interface module being operable to: receive initial form data from the web-based database application and transfer that data to Flash objects; and receive Flash object data and transfer that data back to the web-client for placement into the form.
Patent CA-2584573-A1 (CA)
Inventor: REGAN PAUL
IPC: A61L9/16
Filed: 2007-04-11
Abstract: A storage and drying unit for storing and drying outerwear, sports clothing or equipment is provided. The unit comprises an enclosure having a back wall, a top wall, and two side walls defining at least one chamber with an open front. The chamber may also include shelf members for supporting the outerwear, sports clothing or equipment. The walls and any shelf members include aeration holes for allowing movement of air through the chamber in order to facilitate the drying of the outerwear, sports clothing or equipment placed in the chamber. The unit may be provided with a drying fan to encourage an airflow past the outerwear, sports clothing or equipment in the chamber to facilitate drying of same. The unit may also be provided with hangars for hanging the outerwear, sports clothing or equipment. These hangars are sized and shaped to be removably inserted into any one of the aeration holes.
Patent CA-2585650-A1 (CA)
Inventor: OTT GREGOR
IPC: B65D51/22
Filed: 2005-11-04
Abstract: The self-opening closure comprises a pouring spout (3), a screw cap (1) and a self-opening cylinder (2) which is disposed inside the pouring spout (3) and can be set rotating by the screw cap (1). The self-opening cylinder (2), on its lower rim and protruding therefrom, comprises three combined piercing and cutting elements (5, 6, 7). These elements are disposed on two opposite positions on the periphery and in a position between the two. The interior of the self-opening cylinder (2) is provided with three nail-type integrally molded elements (9, 10, 11) which are evenly distributed across the periphery and extend towards the center of the cylinder and have a nail shank (12) and a nail head (13). The nail shank (12) and the bottom side of the nail head of every integrally molded element acts as a guide for one of the three cylinder wall segments that are located on the interior of the cap concentrically to the axis of rotation of the cap. The screw cap (1), on is lower rim (25), is connected to a flat retaining element (21) via at least two material bridges (22, 23, 24) that extend non-radially in relation thereto and that are configured as predetermined breaking points. Said retaining element can engage with the flange (20) of the pouring spout (3) in a horizontal position by means of pins.
Patent CA-2588729-A1 (CA)
Inventor: MIURA KATSUYORI
IPC: F16L1/038
Filed: 2007-05-16
Abstract: A tubular pipe lining material impregnated with a thermosetting resin is inserted into a pipeline and made to expand and press against an inner peripheral surface thereof.  Hot water or steam is sprayed onto the pipe lining material to cure the thermosetting resin impregnated therein. Hot water that has accumulated in a bottom part of the pipe lining material is pumped out to an external location by a pump and cooled by a cooling device to generate cool water, which is then sprayed via a hose onto the cured pipe lining material to thereby cool the heated pipe lining material.  This enables the thermally cured pipeline lining material to be reliably cooled and rendering a water truck unnecessary that is required at a construction site to supply additional cooling water.
Patent CA-2593011-A1 (CA)
Inventor: KOSINSKI ANTHONY J
IPC: A61M5/315
Filed: 2006-01-04
Abstract: A flush syringe assembly (20) comprises a barrel (21) including a cylindrical side wall (22) having an inside surface (23) defining a chamber (25) for retaining fluid, an open proximal end (27) and a distal end (28) having a passageway therethrough in fluid communication with the chamber (25) . A  plunger (37) including an elongate body portion (38) having a stopper (41) at its distal end (40) is provided. The stopper (41) is slidably positioned in fluid-tight engagement with the inside surface (23) of the barrel (21) for driving fluid out of the chamber (25) through the passageway. The stopper (41) includes a distal portion (62) and a proximal portion (61) separated by a spring element (63) and configured to compress when fluid is being driven through the passageway by motion of the plunger (37) and to continue to drive fluid through the passageway after motion of the plunger (37) has stopped.
Patent CA-2593381-A1 (CA)
Title: Processes for producing 7-isoindolinequinolonecarboxylic acid derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and compositions containing the same as active ingredient
Inventor: YAMADA MINORU
IPC: C07D215/56
Filed: 1998-10-27
Abstract: This invention relates to processes for producing a 7-isoindoline-quinolonecarboxylic acid derivative represented by the general formula Ä1Ü which is useful as an antibacterial agent, and an intermediate thereof: <CHEM> wherein R<1> represents a hydrogen atom or a carboxyl-protecting group; R<2> represents a substituted or unsubstituted alkyl, alkenyl, cycloalkyl, aryl or heterocyclic group; R<3> represents at least one group selected from hydrogen atom, halogen atoms, substituted or unsubstituted alkyl, alkenyl, cycloalkyl, aryl, alkoxy or alkylthio groups, nitro group, cyano group, acyl groups, protected or unprotected hydroxyl groups and protected or unprotected or substituted or unsubstituted amino groups; R<4> represents at least one group selected from hydrogen atom, halogen atoms, substituted or unsubstituted alkyl, alkenyl, cycloalkyl, aralkyl, aryl, alkoxy or alkylthio groups, protected or unprotected hydroxyl or imino groups, protected or unprotected or substituted or unsubstituted amino groups, alkylidene groups, oxo group and groups each forming a cycloalkane group together with the carbon atom to which R<4> bonds; R<5> represents a hydrogen atom, an amino-protecting group, a substituted or unsubstituted alkyl, cycloalkyl, alkylsulfonyl, arylsulfonyl, acyl or aryl group; R<6> represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl, alkoxy or alkylthio group, a protected or unprotected hydroxyl or amino group or a nitro group; and A represents CH or C-R<7> in which R<7> represents a halogen atom, a substituted or unsubstituted alkyl, alkoxy or alkylthio group or a protected or unprotected hydroxyl group, and to a salt of a 7-isoindoline-quinolonecarboxylic acid represented by the general formula Ä1Ü, a hydrate thereof and a composition comprising them as an active ingredient.
Patent CA-2595634-A1 (CA)
Title: Automatic identification of repeated material in audio signals
Inventor: LI-CHUN WANG AVERY
IPC: G06K9/00
Filed: 2006-02-08
Abstract: A system and method are described for recognizing repeated audio material within at least one media stream without prior knowledge of the nature of the repeated material. The system and method are able to create a screening database from the media stream or streams. An unknown sample audio fragment is taken from the media stream and compared against the screening database to find if there are matching fragments within the media streams by determining if the unknown sample matches any samples in the screening database.
Patent CA-2596101-A1 (CA)
Title: Method for imaging and differential analysis of cells
Inventor: SEO MICHAEL J
IPC: G01N33/50
Filed: 2005-03-16
Abstract: Provided are methods for determining and analyzing photometric and morphogenic features of small objects, such as cells to, for example, identify different cell states. In particularly, methods are provided for identifying apoptotic cells, and for distinguishing between cells undergoing apoptosis versus necrosis.